Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)
- 1 March 2011
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 59 (3) , 438-446
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Role of Bacillus Calmette-Guérin in the Treatment of Non–Muscle-Invasive Bladder CancerEuropean Urology, 2010
- EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the BladderEuropean Urology, 2008
- Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 UpdateJournal of Urology, 2007
- EAU Guidelines on the Diagnosis and Treatment of Urothelial Carcinoma in SituEuropean Urology, 2005
- Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical TrialsJournal of Urology, 2002
- Transurethral Resection and Sequential Chemo–Immunoprophylaxis in Primary T1G3 Bladder CancerEuropean Urology, 2000
- RESULTS OF A RANDOMIZED PHASE III TRIAL OF SEQUENTIAL INTRAVESICAL THERAPY WITH MITOMYCIN C AND BACILLUS CALMETTE-GUERIN VERSUS MITOMYCIN C ALONE IN PATIENTS WITH SUPERFICIAL BLADDER CANCERJournal of Urology, 1998
- Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Therapy for Carcinoma in Situ of the BladderJournal of Urology, 1995
- The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Gu rin for prophylaxis of recurrence of superficial bladder cancer: a preliminary reportCancer Chemotherapy and Pharmacology, 1994
- Cytostatic effect of different strains of Bacillus Calmette-Gu rin on human bladder cancer cells in vitro alone and in combination with mitomycin C and Interferon-?Urological Research, 1992